Heart Failure in Focus - Ep 5: Functional & QoL Outcomes in a Sea of Clinical Event Data
This month we are joined by Dr Mikhail Kosiborod, clinical trialist, Professor of Medicine at St Luke’s Heart Institute and leading expert on Quality of Life (QoL) instruments worldwide.
Dr Kosiborod discusses functional and QoL outcomes of foundational therapies in Heart Failure (HF) and the clinical application of this data. Additionally, we learn how scoring systems like the Kansas City Cardiomyopathy Questionnaire (KCCQ) can be used to establish clinically meaningful change in functional status. Finally, we consider how regulators future guideline development might start to look beyond the New York Heart Association (NYHA) classification and embrace QoL and overall health status when assessing HF treatments.
Questions can be sent via Twitter to our host @mvaduganathan or to @radcliffeCARDIO.
Listen to more episodes from Heart Failure in Focus.
Read MoreRead Less
This podcast is supported by an unrestricted educational grant from AstraZeneca.
Read MoreRead Less
In this month's episode, our host Dr Muthiah Vaduganathan speaks with Dr Kieran McCafferty, Consultant Nephrologist at Barts NHS Health Trust London, and Senior Clinical Lecturer at Queen Mary University of London, about the growing need for effective management strategies in cardiorenal disease.
Questions can be sent via Twitter to our host @mvaduganathan or to @radcliffeCARDIO.
This podcast is supported by an unrestricted educational grant from AstraZeneca.
Read More
Questions can be sent via Twitter to our host @mvaduganathan or to @radcliffeCARDIO.
This podcast is supported by an unrestricted educational grant from AstraZeneca.
All Episodes
In the final episode of Heart Failure in Focus for 2023, Dr Muthiah Vaduganathan is joined by Prof Giuseppe Rosano (St George’s Hospital London, UK), who played a central part in the development of the 2023 European heart failure guideline focussed update and an earlier publication on HFpEF phenotyping.
This podcast is supported by an unrestricted educational grant from AstraZeneca.
Read More
This podcast is supported by an unrestricted educational grant from AstraZeneca.
In this month's episode, our host Dr Muthiah Vaduganathan speaks with Prof Xavier Cos, a general practitioner and Innovation Officer at Institut Català de la Salut, Barcelona, ES, and Chairman of Primary Care Diabetes Europe, to discuss the current and future role of primary care in heart failure (HF).
This podcast is supported by an unrestricted educational grant from AstraZeneca.
Read More
This podcast is supported by an unrestricted educational grant from AstraZeneca.
In this month's episode, our host Dr Muthiah Vaduganathan speaks with Dr Kieran McCafferty, Consultant Nephrologist at Barts NHS Health Trust London, and Senior Clinical Lecturer at Queen Mary University of London, about the growing need for effective management strategies in cardiorenal disease.
Questions can be sent via Twitter to our host @mvaduganathan or to @radcliffeCARDIO.
This podcast is supported by an unrestricted educational grant from AstraZeneca.
Read More
Questions can be sent via Twitter to our host @mvaduganathan or to @radcliffeCARDIO.
This podcast is supported by an unrestricted educational grant from AstraZeneca.
This month we are joined by Dr Mikhail Kosiborod, clinical trialist, Professor of Medicine at St Luke’s Heart Institute and leading expert on Quality of Life (QoL) instruments worldwide. Dr Kosiborod discusses functional and QoL outcomes of foundational therapies in Heart Failure (HF) and the clinical application of this data.
Questions can be sent via Twitter to our host @mvaduganathan or to @radcliffeCARDIO.
This podcast is supported by an unrestricted educational grant from AstraZeneca.
Read More
Questions can be sent via Twitter to our host @mvaduganathan or to @radcliffeCARDIO.
This podcast is supported by an unrestricted educational grant from AstraZeneca.
In this month’s episode, we speak with Dr Tariq Ahmad, Chief of Heart Failure at Yale University, and author of several recent behavioural and implementation studies in HF, including REVeAL-HF and PROMPT-HF. In this conversation, we get to grips with the reality of sub-optimal treatment and discuss some possible ways forward using behavioural “nudges” embedded within electronic health records. We also consider the barriers faced in everyday practice that obscure optimal therapy for so many patients.
Questions can be sent via Twitter to our host @mvaduganathan or to @radcliffeCARDIO.
This podcast is supported by an unrestricted educational grant from AstraZeneca.
Read More
Questions can be sent via Twitter to our host @mvaduganathan or to @radcliffeCARDIO.
This podcast is supported by an unrestricted educational grant from AstraZeneca.
This month, we welcome Dr Biykem Bozkurt - the Mary and Gordon Cain Chair and Professor of Medicine at Baylor College of Medicine, Texas – a true pioneer in translational research and a lead contributor to clinical practice guidelines, including the 2022 AHA/ACC/HFSA guidelines.
Questions can be sent via Twitter to our host @mvaduganathan or to @radcliffeCARDIO.
This podcast is supported by an unrestricted educational grant from AstraZeneca.
Read More
Questions can be sent via Twitter to our host @mvaduganathan or to @radcliffeCARDIO.
This podcast is supported by an unrestricted educational grant from AstraZeneca.
Join us for our second podcast in the series where our host Dr Muthiah Vaduganathan continues the theme of SGLT-2 inhibitors in heart failure. This month’s guest is Prof Carolyn Lam who, together with Muthu, will be answering your questions about SGLT-2 inhibitors and the practical management of heart failure patients.
Questions can be sent via Twitter to our host @mvaduganathan or to @radcliffeCARDIO.
This podcast is supported by an unrestricted educational grant from AstraZeneca.
Read More
Questions can be sent via Twitter to our host @mvaduganathan or to @radcliffeCARDIO.
This podcast is supported by an unrestricted educational grant from AstraZeneca.
In this first episode of our new podcast series, Heart Failure in Focus, Dr Muthiah Vaduganathan is joined by Prof Scott Solomon to discuss the DELIVER data which was released at the ESC Congress 2022 in Barcelona. During this fascinating interview, you will get insight into the uniqueness of the DELIVER trial design, the importance of its design for key patient groups and what the results mean for clinical practice.
Questions can be sent via Twitter to our host @mvaduganathan or to @radcliffeCARDIO.
This podcast is supported by an unrestricted educational grant from AstraZeneca.
Read More
Questions can be sent via Twitter to our host @mvaduganathan or to @radcliffeCARDIO.
This podcast is supported by an unrestricted educational grant from AstraZeneca.
Presenting our new podcast series Heart Failure in Focus, hosted by Dr Muthiah Vaduganathan.
The first episode will be launched on 28th August. Watch this space!
This podcast is supported by an unrestricted educational grant from AstraZeneca.
Read More
The first episode will be launched on 28th August. Watch this space!
This podcast is supported by an unrestricted educational grant from AstraZeneca.
In the final episode of Heart Failure in Focus for 2023, Dr Muthiah Vaduganathan is joined by Prof Giuseppe Rosano (St George’s Hospital London, UK), who played a central part in the development of the 2023 European heart failure guideline focussed update and an earlier publication on HFpEF phenotyping.
This podcast is supported by an unrestricted educational grant from AstraZeneca.
Read More
This podcast is supported by an unrestricted educational grant from AstraZeneca.
In this month's episode, our host Dr Muthiah Vaduganathan speaks with Prof Xavier Cos, a general practitioner and Innovation Officer at Institut Català de la Salut, Barcelona, ES, and Chairman of Primary Care Diabetes Europe, to discuss the current and future role of primary care in heart failure (HF).
This podcast is supported by an unrestricted educational grant from AstraZeneca.
Read More
This podcast is supported by an unrestricted educational grant from AstraZeneca.
In this month's episode, our host Dr Muthiah Vaduganathan speaks with Dr Kieran McCafferty, Consultant Nephrologist at Barts NHS Health Trust London, and Senior Clinical Lecturer at Queen Mary University of London, about the growing need for effective management strategies in cardiorenal disease.
Questions can be sent via Twitter to our host @mvaduganathan or to @radcliffeCARDIO.
This podcast is supported by an unrestricted educational grant from AstraZeneca.
Read More
Questions can be sent via Twitter to our host @mvaduganathan or to @radcliffeCARDIO.
This podcast is supported by an unrestricted educational grant from AstraZeneca.
This month we are joined by Dr Mikhail Kosiborod, clinical trialist, Professor of Medicine at St Luke’s Heart Institute and leading expert on Quality of Life (QoL) instruments worldwide. Dr Kosiborod discusses functional and QoL outcomes of foundational therapies in Heart Failure (HF) and the clinical application of this data.
Questions can be sent via Twitter to our host @mvaduganathan or to @radcliffeCARDIO.
This podcast is supported by an unrestricted educational grant from AstraZeneca.
Read More
Questions can be sent via Twitter to our host @mvaduganathan or to @radcliffeCARDIO.
This podcast is supported by an unrestricted educational grant from AstraZeneca.
In this month’s episode, we speak with Dr Tariq Ahmad, Chief of Heart Failure at Yale University, and author of several recent behavioural and implementation studies in HF, including REVeAL-HF and PROMPT-HF. In this conversation, we get to grips with the reality of sub-optimal treatment and discuss some possible ways forward using behavioural “nudges” embedded within electronic health records. We also consider the barriers faced in everyday practice that obscure optimal therapy for so many patients.
Questions can be sent via Twitter to our host @mvaduganathan or to @radcliffeCARDIO.
This podcast is supported by an unrestricted educational grant from AstraZeneca.
Read More
Questions can be sent via Twitter to our host @mvaduganathan or to @radcliffeCARDIO.
This podcast is supported by an unrestricted educational grant from AstraZeneca.